Literature DB >> 16338065

Aurora-A overexpression associates with Ha-ras codon-12 mutation and blackfoot disease endemic area in bladder cancer.

Ya-Shih Tseng1, Ching-Cherng Tzeng, Chi-Ying F Huang, Ping-Hong Chen, Allen Wen-Hsiang Chiu, Pei-Yin Hsu, Guan-Cheng Huang, Yu-Chun Wang, Hsiao-Sheng Liu.   

Abstract

Our data revealed that 59.4% of the bladder cancer specimens showed Aurora-A overexpression, of which 31.8% also had Ha-ras codon-12 mutation; 45.5% were from blackfoot-disease endemic areas in which arsenic exposure is a major environment factor associated with various cancer formation. We further demonstrated that arsenic treatment of the immortalized bladder cell line, E7, increased Aurora-A expression. All together, co-existence of Aurora-A overexpression and Ha-ras mutation suggests a possible additively effect on the tumorigenesis of bladder cancer. In addition, Aurora-A overexpression and up-regulated by arsenic exposure opens a new direction for exploring the occurrence of bladder cancer occurrence in Taiwan.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338065     DOI: 10.1016/j.canlet.2005.10.014

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  Ras-related tumorigenesis is suppressed by BNIP3-mediated autophagy through inhibition of cell proliferation.

Authors:  Shan-Ying Wu; Sheng-Hui Lan; Da-En Cheng; Wei-Kai Chen; Cheng-Huang Shen; Ying-Ray Lee; Roberto Zuchini; Hsiao-Sheng Liu
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer.

Authors:  Jayoung Kim; Wun-Jae Kim; Zhiqian Liu; Massimo Loda; Michael R Freeman
Journal:  Cell Cycle       Date:  2012-03-15       Impact factor: 4.534

3.  RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis.

Authors:  Gong Yang; Imelda Mercado-Uribe; Asha S Multani; Subrata Sen; Ie-Ming Shih; Kwong-Kwok Wong; David M Gershenson; Jinsong Liu
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

4.  Aurora kinase A interacts with H-Ras and potentiates Ras-MAPK signaling.

Authors:  MaKendra Umstead; Jinglin Xiong; Qi Qi; Yuhong Du; Haian Fu
Journal:  Oncotarget       Date:  2017-04-25

5.  Arsenic treatment increase Aurora-A overexpression through E2F1 activation in bladder cells.

Authors:  Yu-Ting Kao; Chin-Han Wu; Shan-Ying Wu; Sheng-Hui Lan; Hsiao-Sheng Liu; Ya-Shih Tseng
Journal:  BMC Cancer       Date:  2017-04-18       Impact factor: 4.430

6.  Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway.

Authors:  Ya-Shih Tseng; Jenq-Chang Lee; Chi-Ying F Huang; Hsiao-Sheng Liu
Journal:  BMC Cancer       Date:  2009-12-12       Impact factor: 4.430

7.  Cyclooxygenase-2 expression in the tumor environment is associated with poor prognosis in colorectal cancer patients.

Authors:  Peng-Chan Lin; Yih-Jyh Lin; Chung-Ta Lee; Hsiao-Sheng Liu; Jenq-Chang Lee
Journal:  Oncol Lett       Date:  2013-06-26       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.